Resultats globals: 4 registres trobats en 0.01 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
11 p, 1.2 MB Women's Health in Multiple Sclerosis : A Scoping Review / Ross, Lindsay (Mellen Center for Multiple Sclerosis Treatment and Research. Department of Neurology) ; Ng, Huah Shin (University of British Columbia. Department of Medicine) ; O'Mahony, Julia (University of Manitoba. Department of Internal Medicine) ; Amato, Maria Pia (University of Florence) ; Cohen, Jeffrey A. (Mellen Center for Multiple Sclerosis Treatment and Research. Department of Neurology) ; Harnegie, Mary Pat (Cleveland Clinic) ; Hellwig, Kerstin (Ruhr University. Department of Neurology) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Vukusic, Sandra (Université Claude Bernard Lyon 1) ; Marrie, Ruth Ann (University of Manitoba. Department of Community Health Sciences) ; Universitat Autònoma de Barcelona
Women with multiple sclerosis (MS) may face challenges related to managing reproduction, pregnancy, and menopause while simultaneously managing their disease. The purpose of this scoping review was to map the literature broadly related to topics relevant to women's health in MS to inform the clinical and research communities about the existing types and sources of evidence and knowledge gaps. [...]
2022 - 10.3389/fneur.2021.812147
Frontiers in neurology, Vol. 12 (january 2022)  
2.
6 p, 333.0 KB Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab / Fissolo, Nicolás (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pignolet, Beatrice (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rio, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vermersch, Patrick (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ruet, Aurélie (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; deSèze, Jerome (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Labauge, Pierre (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Vukusic, Sandra (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Papeix, Caroline (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martinez-Almoyna, Laurent (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tourbah, Ayman (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Clavelou, Pierre (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Moreau, Thibault (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pelletier, Jean (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Lebrun-Frenay, Christine (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Bourre, Bertrand (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Defer, Gilles (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Brassat, David (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
The study aimed to assess the potential for serum neurofilament light chain (NFL) levels to predict the risk of progressive multifocal leukoencephalopathy (PML) in natalizumab (NTZ)-treated patients with multiple sclerosis (MS) and to discriminate PML from MS relapses. [...]
2021 - 10.1212/NXI.0000000000001003
Neurology® neuroimmunology & neuroinflammation, Vol. 8 (april 2021)  
3.
14 p, 930.3 KB Aggressive multiple sclerosis (1) : Towards a definition of the phenotype / Iacobaeus, Ellen (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Amato, Maria Pia (Università degli Studi Firenze) ; Derfuss, Tobias (University Hospital Basel (Basilea, Suïssa)) ; Vukusic, Sandra (Hôpital Neurologique Pierre Wertheimer) ; Hemmer, Bernhard (Technical University of Munich) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Brundin, Lou (Karolinska University Hospital and Karolinska Institutet (Suècia)) ; Universitat Autònoma de Barcelona
While the major phenotypes of multiple sclerosis (MS) and relapsing-remitting, primary and secondary progressive MS have been well characterized, a subgroup of patients with an active, aggressive disease course and rapid disability accumulation remains difficult to define and there is no consensus about their management and treatment. [...]
2020 - 10.1177/1352458520925369
Multiple sclerosis, Vol. 26 (june 2020) , p. 1031-1044  
4.
19 p, 669.3 KB Aggressive multiple sclerosis (2) : Treatment / Arrambide, Georgina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Iacobaeus, Ellen ; Amato, Maria Pia ; Derfuss, Tobias ; Vukusic, Sandra ; Hemmer, Bernhard ; Brundin, Lou ; Tintoré, Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
The natural history of multiple sclerosis (MS) is highly heterogeneous. A subgroup of patients has what might be termed aggressive MS. These patients may have frequent, severe relapses with incomplete recovery and are at risk of developing greater and permanent disability at the earlier stages of the disease. [...]
2020 - 10.1177/1352458520924595
Multiple sclerosis, Vol. 26 (june 2020) , p. 1045-1063  

Vegeu també: autors amb noms similars
1 Vukusic, S.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.